| Style | Citing Format |
|---|---|
| MLA | Ansari R, Taghizadehghehi M. "Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients”." Journal of Oncology Pharmacy Practice, vol. 29, no. 8, 2023, pp. 2057-2058. |
| APA | Ansari R, Taghizadehghehi M (2023). Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients”. Journal of Oncology Pharmacy Practice, 29(8), 2057-2058. |
| Chicago | Ansari R, Taghizadehghehi M. "Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients”." Journal of Oncology Pharmacy Practice 29, no. 8 (2023): 2057-2058. |
| Harvard | Ansari R, Taghizadehghehi M (2023) 'Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients”', Journal of Oncology Pharmacy Practice, 29(8), pp. 2057-2058. |
| Vancouver | Ansari R, Taghizadehghehi M. Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients”. Journal of Oncology Pharmacy Practice. 2023;29(8):2057-2058. |
| BibTex | @article{ author = {Ansari R and Taghizadehghehi M}, title = {Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients”}, journal = {Journal of Oncology Pharmacy Practice}, volume = {29}, number = {8}, pages = {2057-2058}, year = {2023} } |
| RIS | TY - JOUR AU - Ansari R AU - Taghizadehghehi M TI - Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients” JO - Journal of Oncology Pharmacy Practice VL - 29 IS - 8 SP - 2057 EP - 2058 PY - 2023 ER - |